Source control: treating opioid use disorder among inpatients with related infections, an urgent call to action.
| Title: | Source control: treating opioid use disorder among inpatients with related infections, an urgent call to action. |
|---|---|
| Authors: | McCrary LM; Division of Infectious Diseases, Department of Medicine.; Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, North Carolina.; Solomon DA; Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. |
| Source: | AIDS (London, England) [AIDS] 2023 Oct 01; Vol. 37 (12), pp. 1901-1903. |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE |
| Imprint Name(s): | Publication: 1998- : London, England : Lippincott Williams & Wilkins; Original Publication: London : Gower Academic Journals, c1987- |
| MeSH Terms: | HIV Infections* ; Opioid-Related Disorders*; Humans ; Inpatients |
| References: | Bradley H, Hall EW, Asher A, Furukawa NW, Jones CM, Shealey J, et al. Estimated number of people who inject drugs in the United States . Clin Infect Dis 2023; 76:96–102.; Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013–2019 . MMWR Morb Mortal Wkly Rep 2021; 70:202–207.; Understanding the opioid overdose epidemic | Opioids | CDC. Published 7 October 2022. Available at: https://www.cdc.gov/opioids/basics/epidemic.html . [Accessed 25 June 2023].; Wheeler A, Valerio H, Cunningham EB, Martinello M, Barocas JA, Colledge-Frisby S, et al. ETHOS Engage Study Group. Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: the ETHOS Engage Study . Drug Alcohol Depend 2022; 237:109543.; Schranz A, Barocas JA. Infective endocarditis in persons who use drugs: epidemiology, current management, and emerging treatments . Infect Dis Clin North Am 2020; 34:479–493.; Capizzi J, Leahy J, Wheelock H, Garcia J, Strnad L, Sikka M, et al. Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018 . PLoS One 2020; 15:e0242165.; Tsui JI, Evans JL, Lum PJ, Hahn JA, Page K. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users . JAMA Internal Medicine 2014; 174:1974–1981.; Sullivan LE, Moore BA, Chawarski MC, Pantalon MV, Barry D, O’Connor PG, et al. Buprenorphine/naloxone treatment in primary care is associated with decreased HIV risk behaviors . J Subst Abuse Treat 2008; 35:87–92.; MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis . BMJ 2012; 345:e5945.; Lewer D, Eastwood B, White M, Brothers TD, McCusker M, Copeland C, et al. Fatal opioid overdoses during and shortly after hospital admissions in England: a case-crossover study . PLoS Med 2021; 18:e1003759.; Rosenthal ES, Brokus C, Sun J, Carpenter JE, Catalanotti J, Eaton EF, et al. Undertreatment of opioid use disorder in patients hospitalized with injection drug use-associated infections . AIDS 2023; 37:1799–1809.; Barocas JA, Morgan JR, Wang J, McLoone D, Wurcel A, Stein MD. Outcomes associated with medications for opioid use disorder among persons hospitalized for infective endocarditis . Clin Infect Dis 2021; 72:472–478.; Kimmel SD, Walley AY, Li Y, Linas BP, Lodi S, Bernson D, et al. Association of treatment with medications for opioid use disorder with mortality after hospitalization for injection drug use-associated infective endocarditis . JAMA Netw Open 2020; 3:e2016228.; Englander H, Dobbertin K, Lind BK, Nicolaidis C, Graven P, Dorfman C, Korthuis PT. Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis . J Gen Intern Med 2019; 34:2796–2803.; Marks LR, Munigala S, Warren DK, Liang SY, Schwarz ES, Durkin MJ. Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder . Clin Infect Dis 2019; 68:1935–1937.; Serota DP, Rosenbloom L, Hervera B, Seo G, Feaster DJ, Metsch LR, et al. Integrated infectious disease and substance use disorder care for the treatment of injection drug use-associated infections: a prospective cohort study with historical control . Open Forum Infect Dis 2023; 10:ofac688.; Jo Y, Nosal R, Vittori A, Cordova L, Vandever C, Alvarez C, et al. Effect of initiation of medications for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private hospital system in the United States, 2014-18 . Addiction 2021; 116:2127–2134.; Hoover K, Lockhart S, Callister C, Holtrop JS, Calcaterra SL. Experiences of stigma in hospitals with addiction consultation services: a qualitative analysis of patients’ and hospital-based providers’ perspectives . J Subst Abuse Treat 2022; 138:108708.; Waiver Elimination (MAT Act). Published 10 January 2023. Available at: https://www.samhsa.gov/medications-substance-use-disorders/waiver-elimination-mat-act . [Accessed 26 June 2023].; Sen. Markey, EJ [D-MA] S.644 – 118th Congress (2023–2024): Modernizing Opioid Treatment Access Act. Published 2 March 2023. Available at: http://www.congress.gov/bill/118th-congress/senate-bill/644 . [Accessed 28 June 2023]. |
| Entry Date(s): | Date Created: 20230830 Date Completed: 20230831 Latest Revision: 20250608 |
| Update Code: | 20260130 |
| DOI: | 10.1097/QAD.0000000000003663 |
| PMID: | 37646589 |
| Database: | MEDLINE |
Journal Article